-
Product Insights
New![]()
Net Present Value Model: Molecular Templates Inc’s MT-0169
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Molecular Templates Inc’s MT-5111
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Molecular Templates Inc’s MT-0169
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Net Present Value Model: Molecular Partners AG’s MP-0317
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Company Profile
![]()
Molecular Partners AG – Company Profile
Molecular Partners AG (Molecular Partners) is a clinical-stage bio-pharmaceutical company that develops biological drugs. The company offers advanced small protein therapies such as abicipar, a designed ankyrin repeat protein-based anti-angiogenic drug developed for diabetic macular edema and wet age- macular degeneration. It also develops drugs on DARPin base technology and other product candidates. Molecular Partners develops products for ophthalmic conditions, cancer, immune disorders and other indications. The company also provides clinical trial services and small protein therapies called Darpin therapeutics....
Add to Basket -
Company Profile
![]()
Molecular Templates Inc – Company Profile
Molecular Templates Inc (MTI), formerly Threshold Pharmaceuticals Inc, is a clinical-stage oncology company. The company discovers and develops biologic therapeutics for cancer. It’s pipeline products include MT-5111, SLAMF-7, CTLA-4, MT-0169 and MT-6402. MTI lead product MT-3724, a fusion protein, is designed for the treatment of Non-Hodgkin Lymphoma, and MT-0169 is used for the treatment of multiple myeloma. The company also develops Engineered Toxin Bodies (ETBs) for the treatment of breast cancer, melanoma and allogeneic stem cell transplantation. It develops ETBs...
Add to Basket -
Company Profile
![]()
HTG Molecular Diagnostics Inc – Company Profile
HTG Molecular Diagnostics Inc (HTG), is a provider of instruments, reagents, and services for molecular profiling applications. The company's products include HTG edge system, HTG edgeseq reveal software and HTG edgeseq immuno-oncology assay. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also offers autoimmune panel, immuno-oncology assay, dlbcl cell of origin assay, lung fusions assay, miRNA whole transcriptome assay, mouse mRNA tumor response panel, oncology biomarker panel, and precision immuno-oncology...
Add to Basket -
Company Profile
![]()
Applied Molecular Transport Inc – Company Profile
Applied Molecular Transport Inc (AMT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel, oral biological therapeutics for autoimmune, metabolic and inflammatory diseases. The company’s lead product candidate AMT-101, an anti-inflammatory cytokine used for the treatment of inflammatory disorders including ulcerative colitis and other gastrointestinal disorders and AMT-126 for diseases related to IE barrier function defects. AMT provides oral biologic products in tablet and capsule forms targeting gastrointestinal disorders. The company’s proprietary technology platform design and develop various...
Add to Basket -
Product Insights
Miami Univ – Frost Institute of Chemical and Molecular Science – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Miami Univ - Frost Institute of Chemical and Molecular Science - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Arizona Univ – Center for Advanced Molecular and Immunological Therapies – Arizona
Equip yourself with the essential tools needed to make informed and profitable decisions with our Arizona Univ - Center for Advanced Molecular and Immunological Therapies - Arizona report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Arizona Univ – Center for Advanced Molecular and Immunological Therapie – Arizona
Equip yourself with the essential tools needed to make informed and profitable decisions with our Arizona Univ - Center for Advanced Molecular and Immunological Therapie - Arizona report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Saarland Univ – Preclinical Center for Molecular Signal Processing Laboratory – Saarland
Equip yourself with the essential tools needed to make informed and profitable decisions with our Saarland Univ - Preclinical Center for Molecular Signal Processing Laboratory - Saarland report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Polyplast JSC – Novomoskovsk High-Molecular Thermostable Polymer Production Plant – Tula
Equip yourself with the essential tools needed to make informed and profitable decisions with our Polyplast JSC - Novomoskovsk High-Molecular Thermostable Polymer Production Plant - Tula report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Company Profile
![]()
4D Molecular Therapeutics Inc – Company Profile
4D Molecular Therapeutics Inc (4D Molecular Therapeutics) is a gene therapy company that discovers and develops targeted and proprietary AAV gene therapy vectors and therapeutic products. The company’s pipeline products include 4D-125, 4D-110, 4D-150, 4D-135, 4D-310 and 4D-710. It has developed a technology platform, Therapeutic Vector Evolution that empowers to create customized gene delivery vehicles (novel AAV vectors) to deliver genes to any tissue or organ in the body. 4D Molecular Therapeutics develops pipeline products that targets therapeutic areas such...
Add to Basket -
Company Profile
![]()
Molecular Energies PLC – Company Profile
Molecular Energies PLC (Molecular Energies), formerly President Energy PLC, is an independent oil and gas exploration and production company. It focuses mainly on North and South America. The company has a diverse portfolio of operating onshore producing and exploration assets. Its major assets include working interests in Pirity and Hernandarias concessions in the Pirity sub-basin in Paraguay, Puesto Flores and Estancia Vieja concession, Matorras, Puesto Guardian concession and Ocultar fields in Argentina, and East White Lake field and East Lake...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AAA-603 in Metastatic Prostate Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AAA-603 in Metastatic Prostate Cancer Drug Details:AAA-603 is under development for the treatment of multiple solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AAA-603 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AAA-603 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Drug Details:AAA-603...
-
Product Insights
Precision Molecular Inc Pipeline Insight and Competitive Landscape, 2023
Precision Molecular Inc (Precision Molecular) is engaged in developing imaging biomarkers and theragnostic. Precision Molecular is headquartered in Gaithersburg, Maryland, the US. GlobalData's Medical Devices company profile report, “Precision Molecular Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and data related to: Top level information about the company performance and their pipeline products Review details of major pipeline products which include developmental...
-
Product Insights
NeuMoDx Molecular Inc Pipeline Insight and Competitive Landscape, 2023
NeuMoDx Molecular Inc (NMM), a subsidiary of Qiagen NV, provides a platform that integrates the molecular diagnostic process from sample to result. It develops solutions for clinical reference laboratories and molecular diagnostic testing in hospital. The company is headquartered in Ann Arbor, Michigan, the US. GlobalData's Medical Devices company profile report, “NeuMoDx Molecular Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – NME 2 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.NME 2 in Solid Tumor Drug Details: NME 2 is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.